.
AI_133px.jpg
ai
Artificial Intelligence
.
cryptography
crypto
Cryptography
.
materialscience
nano
Materials Science
.
neuroscience
neuroscience
Neuroscience
.
nuclear
nuclear
Nuclear Technologies
.
robotics
robotics
Robotics
.
semiconductor
semiconductors
Semiconductors

KEY TAKEAWAYS

•   Biotechnology is burgeoning, contributing around 5 percent to the US GDP with a historical doubling time of about seven years. 

•   Synthetic biology is third-generation biotechnology, complementing domestication and breeding (the first generation) and gene editing (the second generation).

•   The United States is struggling to grasp the scale of the bio-opportunity, the strategic ramifications unique to network-enabled biotechnologies, and the possibilities and perils of distributed biomanufacturing.

Icons_card_Biotech.png

Overview

Biotechnology creates products or services in partnership with biology. For example, skin microbes can be engineered to combat skin cancer and essential medicines can be brewed from yeast at industrial scales. Biotechnology, already a huge industry—5 percent of GDP— is expected to grow greatly. Synthetic biology, a subset of biotechnology, builds on genetic engineering to focus on improving the composition and functions of living systems. DNA sequencing and synthesis are two fundamental technologies underlying synthetic biology. DNA sequencers are machines that read or decode specific DNA molecules, while synthesizers write user-specified sequences of DNA. The cost of sequencing a human genome has fallen from $10,000 to around $600 in the last decade, while the cost of gene synthesis dropped from $4/base (2003) to $0.04/base (2023).

 

Key Developments

Synthetic biology has applications in medicine, agriculture, manufacturing, and sustainability. DNA and RNA synthesis underlie all mRNA vaccines, including those for COVID-19. Synthetic biology can also cultivate drought-resistant crops and enable cells to be programmed to manufacture medicines or fuel on an agile, distributed basis. 

The “superpower” of the internet—the ability to rapidly move information—can amplify the “superpower” of biology: the ability to grow and assemble complex objects locally. For example, DNA sequencers and synthesizers connected to the internet could routinely allow researchers to distribute vaccines against viruses around the world faster than a pandemic can spread. Developed wisely, such capabilities could lead to biodefense and public health systems operating at light speed. Ignored or mismanaged, such capabilities could result in widespread access to bioterror capabilities or worse. Artificial intelligence will likely supercharge synthetic biology, starting with molecular, pathway, and cellular design.

Over the Horizon

For biology to develop fully as a technology, careful attention and sustained support for improving the methods underlying biotechnology overall are essential. Whoever develops the tools for measuring, modeling, and making with biology has a chance of being world leading. Whoever first unlocks routinization and coordination of labor in biotechnology workflows and commercialization will cement their leadership. Careful consideration of such needs and opportunities reveals gaps in the nation’s portfolio (e.g., the National Institute of Standards and Technology should be resourced to develop and advance standards and reference materials undergirding a networked bioeconomy). 

The building blocks for a federal strategic vision released in 2022 (including the National Engineering Biology Research and Development Initiative, National Biotechnology and Biomanufacturing Initiative, National Security Memorandum 15, and National Security Commission on Emerging Biotechnology) tend to focus on applications and outcomes. Yet each offers important openings for creating support for foundational bioengineering research; these opportunities must be seized via active multilateral efforts to provide advice and input. The recently launched Global Forum on Technology at the Organisation for Economic Co-operation and Development (OECD) offers an important additional platform for coordination among democracies.

“Patient capital,” both private and public, is crucial for foundational research, since many biotechnologies have long development scales. Such long-term capital must be sustained in times of ebb and flow in the pace of scientific advancement. Although mRNA vaccines came into widespread public knowledge in 2021, their history began thirty years ago, a history that offers humbling lessons regarding lack of vision and support among institutions and programs now happy to claim credit for success. 

From a strategic perspective, we are tracking four areas of significant consequence and opportunity: 
(1) progress toward constructing life from scratch (e.g., building a cell); 
(2) advances in electrobiosynthesis (i.e., growing biomass starting from renewable electricity and atmospheric carbon); 
(3) advances in next-generation DNA synthesis, including a potential return to desktop synthesis; and 
(4) progress toward profitability (e.g., when synthetic biology companies realize and sustain significant profits). 

 

REPORT PREVIEW: Biotechnology Synthetic Biology

Faculty Council Advisor

drew-endy_profilephoto.jpg
Drew Endy
Author
Drew Endy

Drew Endy is the Martin Family University Fellow in Undergraduate Education (bioengineering), codirector of degree programs for the Hasso Plattner Institute of Design (the d.school), core faculty at the Center for International Security and Cooperation (CISAC), and senior fellow (courtesy) of the Hoover Institution at Stanford University. He serves as president and director of the Biobricks Foundation and director of the iGEM Foundation and the Biobuilder Educational Foundation. His research focuses on the foundations of synthetic biology along with broader societal aspects. He earned a PhD in biotechnology and biochemical engineering from Dartmouth College.

View Bio
drew-endy_profilephoto.jpg
Drew Endy

Drew Endy is the Martin Family University Fellow in Undergraduate Education (bioengineering), codirector of degree programs for the Hasso Plattner Institute of Design (the d.school), core faculty at the Center for International Security and Cooperation (CISAC), and senior fellow (courtesy) of the Hoover Institution at Stanford University. He serves as president and director of the Biobricks Foundation and director of the iGEM Foundation and the Biobuilder Educational Foundation. His research focuses on the foundations of synthetic biology along with broader societal aspects. He earned a PhD in biotechnology and biochemical engineering from Dartmouth College.

Access the Complete Report

Read the complete report.

Explore

Date Range
CONTENT TYPE

Select Content Type

  • News
  • Article
  • Videos
  • Podcasts
  • Events
AUTHORS

Select Author

  • Condoleezza Rice
  • John Taylor
  • Jennifer Widom
  • Amy Zegart
  • Herbert Lin
  • Hon. Jerry McNerney
  • Hon. Robert Gates
  • Hon. Steven Chu
  • Hon. Susan M. Gordon
  • John Hennessy
  • Lloyd B. Minor
  • Mary Meeker
  • Peter Scher
  • Thomas M. Siebel
  • Zhenan Bao
  • Dan Boneh
  • Yi Cui
  • Simone D’Amico
  • Drew Endy
  • Siegfried Glenzer
  • Mark A. Horowitz
  • Fei-Fei Li
  • Allison Okamura
  • Kang Shen
  • Eric Schmidt
  • Steven Koonin
  • Sally Benson
  • Norbert Holtkamp
FOCUS AREAS

Biotechnology and Synthetic Biology

  • Artificial Intelligence
  • Biotechnology and Synthetic Biology
  • Sustainable Energy Technologies
  • Cryptography
  • Materials Science
  • Neuroscience
  • Nuclear Technologies
  • Robotics
  • Semiconductors
  • Space
  • Technology Test Page
  • Lasers
Date (field_date)
Read More
EnvironmentiStock-1459230107.jpg
Article
Books
Sustainable Energy: Powering the Future

In search of scalable solutions for generating, moving, and storing energy.

November 06, 2024
Read More
Simone-D'Amico-Headshot1000px.jpg
News
Books
Navigating the Challenges of Space: Balancing Progress and Preservation for Future Generations

Simone D’Amico, science fellow at the Hoover Institution, is associate professor of aeronautics and astronautics, the W. M. Keck Faculty Scholar in the School of Engineering, and professor of geophysics (by courtesy) at Stanford University. He is the founding…

October 31, 2024
Read More
Code iStock
Article
Books
Cryptography: A Shield for Secrets and Security

Protecting data is essential for commerce and communication. New threats leave no room for complacency.

October 10, 2024
Read More
Human brain
Article
Books
Neuroscience: Unlocking the Brain’s Secrets

Drugs and therapies could bring about longer lives, better mental health, and freedom from addiction.

September 18, 2024
Read More
SETR SyntheticBio
Videos
Books
The Future Of Synthetic Biology

At the frontier of biotech innovation, synthetic biology promises revolutionary advancements in agriculture, health and medicine, energy, and more. The ability to better understand and encode life’s building blocks, has the potential to improve the environment…

September 09, 2024 by Drew Endy
Read More
drew-endy_705px .jpg
News
Books
How Bio-Bonds Can Help Build World-Class Biomanufacturing Infrastructure Across America

Seven Questions for Drew Endy, Hoover Science Fellow from Hoover's Technology Policy Accelerator.

September 09, 2024
Read More
Materials Science
Article
Books
Materials Science: Building the Tech Future

Researchers are finding, transforming, and creating the material building blocks of science and industry.

July 26, 2024
Read More
Space
Article
Books
A Deeper Dive into Space

Stanford University experts survey the aeronautics and astronautics research landscape on campus, covering topics including multisatellite autonomy; in-space logistics, servicing, assembly, and manufacturing (ISAM); space sustainability; spacecraft systems and…

June 17, 2024 by Herbert Lin, Simone D’Amico
Read More
Semiconductor Day at the Hoover Institution
News
Books
Experts, Diplomats, and Industry Representatives Discuss US Semiconductor Future after Passage of CHIPS Act

As dollars from the CHIPS and Science Act flow to strengthen the US semiconductor industry, senior leaders from the US government, industry, academia, and international partners met at the Hoover Institution to discuss current challenges and the field’s next…

June 13, 2024
Read More
SETR_CongressionalFellowship
News
Books
Stanford Emerging Technology Review Congressional Fellowship Program

The Hoover Institution and Stanford School of Engineering appreciate the important role of Congressional staff as they advise Members on the critically important policy issues that routinely come before Congress.

March 21, 2024

You May Also Like

.
SETR SyntheticBio
The Future Of Synthetic Biology
.
Artificial Intelligence
Stanford aims to help policy makers prepare for AI, robotics and more
.
Artificial Intelligence
Stanford launches emerging-tech project co-led by Hoover Institution’s Condoleezza Rice
overlay image